Evidence map›Paper›PMID 35699469›Full record

ArticleMicrobiology spectrum2022

Mutual Exclusion of

Adrian Low, Jolie Kar Yi Lee, Jean-Sebastien Gounot, Aarthi Ravikrishnan, Yichen Ding, Woei-Yuh Saw, Linda Wei Lin Tan, Don Kyin Nwe Moong, Yik Ying Teo, Niranjan Nagarajan and 1 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Microbiology spectrum · 2024
    Article
  12. Journal of oral microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Adrian LowTemasek Life Sciences Laboratorygrid.226688.0, Singapore.ORCID 0000-0003-0997-2490
Jolie Kar Yi LeeTemasek Life Sciences Laboratorygrid.226688.0, Singapore.
Jean-Sebastien GounotGenome Institute of Singapore, A*STAR, Singapore.
Aarthi RavikrishnanGenome Institute of Singapore, A*STAR, Singapore.
Yichen DingTemasek Life Sciences Laboratorygrid.226688.0, Singapore.
Woei-Yuh SawBaker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Linda Wei Lin TanSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Don Kyin Nwe MoongSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Yik Ying TeoGenome Institute of Singapore, A*STAR, Singapore.
Niranjan NagarajanGenome Institute of Singapore, A*STAR, Singapore.
Henning SeedorfTemasek Life Sciences Laboratorygrid.226688.0, Singapore.ORCID 0000-0002-5763-0236

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methanogenic Archaea (methanogens) are a phylogenetically diverse group of microorganisms and are considered to be the most abundant archaeal representatives in the human gut. However, the gut methanogen diversity of human populations in many global regions remains poorly investigated. Here, we report the abundance and diversity of gut methanogenic Archaea in a multi-ethnic cohort of healthy Singaporeans by using a concerted approach of metagenomic sequencing, 16S rRNA gene amplicon sequencing, and quantitative PCR. Our results indicate a mutual exclusion of

Indexed as

Gastrointestinal MicrobiomeMethanobrevibacterFecesHumansMetagenomicsRNA, Ribosomal, 16SRNA, Ribosomal, 16SArchaeahuman gut microbiotaMethanobrevibactermethanogens

Identifiers

PMID35699469
PMCPMC9431525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.